New B Cell Therapy Shows Striking Power Against Neuromyelitis Optica
A phase III trial of obinutuzumab β shows striking efficacy in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorder, deepening questions about which ...
A phase III trial of obinutuzumab β shows striking efficacy in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorder, deepening questions about which ...
MOG antibody-associated disease, or MOGAD, is emerging from the margins of neuroimmunology as clinicians gain a more precise framework for ...
In the realm of infectious diseases, the interplay between viral infections and autoimmune disorders is a burgeoning field of study ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine